Change, change, change: hormonal actions depend on changes in blood levels
Human ReproductionPublished 8 March 2008Open access
Shahar Kol, Roy Homburg
Citations24
SJR quartileQ1
SJR score2.15
SNIP1.78
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
It is hypothesized that changes in hormone concentrations carry significant biological messages, much more than a given level at a given time point and if proved, this theory could give rise to better approaches to treatment, and risk assessment.
Abstract
The main hypothesis outlined in this communication is that changes in hormonal levels are of utmost importance in the female reproductive system physiology. Hormone measurements must be assessed in the context of time and change. We hypothesize that changes in hormone concentrations carry significant biological messages, much more than a given level at a given time point and if proved, this theory could give rise to better approaches to treatment, and risk assessment.
Keywords
Environmental Science
EndocrinologyDynamics of gonadotropin-releasing hormone release during a pulse.
1,243 Citations1992Suzanne M. Moenter, Rhonda M. Brand +2 more
The findings indicate the square-wave pulses observed in vivo are an accurate description of the dynamics of GnRH release during a pulse in short-term overiectomized ewes.
Elsevier eBooksOn the Control of Gonadotropin Secretion in the Rhesus Monkey
377 Citations1974E. Knobil
The tonic secretion of LH and of FSH, as reflected by their concentrations in peripheral plasma at times other than during the preovulatory surge, appears to be controlled by a classical negative feedback loop involving, among other components, the ovary and the gonadotrophs of the adenohypophysis.
The Journal of Clinical Endocrinology & MetabolismSimultaneous Radioimmunoassay of Plasma FSH, LH, Progesterone, 17-Hydroxyprogesterone, and Estradiol-17β During the Menstrual Cycle
342 Citations1972Guy E. Abraham, William D. Odell +2 more
The data suggest that in women, there is a relationship between the steroids 17-OHP and E2, and the mid-cycle peaks were observed in every normal cycle studied.
Fertility and SterilityIncidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles
340 Citations2006Evangelos Papanikolaou, Cristina Pozzobon +6 more
Clinically significant OHSS still remains a limitation of multifollicular ovarian stimulation for IVF even with the use of GnRH antagonist protocols and the number of follicles can discriminate the patients who are at risk for developing OHSS, whereas E2 concentrations are less reliable for the purpose of prediction.
Human ReproductionA double-blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon). The ganirelix dose-finding study group
293 Citations1998
A daily dose of 0.25 mg Org 37462 prevented LH surges during ovarian stimulation and resulted in a good clinical outcome, including an ongoing pregnancy rate 12-16 weeks after embryo transfer.
Obstetrics and GynecologyRisk Factors for Hyperemesis Gravidarum Requiring Hospital Admission During Pregnancy
272 Citations2006Deshayne B. Fell, Linda Dodds +3 more
Although hospitalization for hyperemesis occurs in less than 1% of pregnant women, this translates to a large number of hospital admissions, so identification of these factors may be useful in determining those women at high risk for developing hyperemises.
Obstetrical & Gynecological SurveyNausea and Vomiting of Pregnancy: Endocrine Basis and Contribution to Pregnancy Outcome
126 Citations2001Edwina C. Furneaux, Alison J. Langley-Evans +1 more
It seems that NVP and hCG are related and that nutrient restriction during critical periods of embryonic development may ensure production of hCG at optimal levels, protect placental development, and optimize nutrient partitioning between maternal and fetal tissues.
Human Reproduction UpdateAmong patients treated with FSH and GnRH analogues for in vitro fertilization, is the addition of recombinant LH associated with the probability of live birth? A systematic review and meta-analysis
116 Citations2007Efstratios M. Κolibianakis, Lydia Kalogeropoulou +5 more
The available evidence does not support the hypothesis that the addition of recombinant LH increases the live birth rate in patients treated with FSH and GnRH analogues for IVF.
Fertility and SterilityEstradiol supplementation during the luteal phase may improve the pregnancy rate in patients undergoing in vitro fertilization-embryo transfer cycles
113 Citations2000Jacob Farhi, Ariel Weissman +4 more
For patients who are treated with the long GnRH analog protocol for controlled ovarian hyperstimulation and for whom luteal support with hCG is contraindicated, the addition of E(2) to the progestin support regimen may have a beneficial effect on pregnancy and implantation rates.
Human ReproductionDose-finding study of daily GnRH antagonist for the prevention of premature LH surges in IVF/ICSI patients: optimal changes in LH and progesterone for clinical pregnancy
91 Citations2004Judith A.F. Huirne, André C.D. van Loenen +6 more
Excessive or insufficient suppression of LH and progesterone levels during GnRH antagonist administration and high progester one/follicle on hCG day seems to be associated with impaired clinical pregnancy rates.
Human ReproductionLuteal phase ovarian oestrogen is not essential for implantation and maintenance of pregnancy from surrogate embryo transfer in the rhesus monkey
79 Citations1994Debabrata Ghosh, Pradip De +1 more
Human Reproduction UpdateAre endogenous LH levels during ovarian stimulation for IVF using GnRH analogues associated with the probability of ongoing pregnancy? A systematic review
75 Citations2005Efstratios M. Κolibianakis, John A. Collins +3 more
Until further prospective studies modify the existing evidence summarized here, an adverse effect of low endogenous LH levels on the probability of ongoing pregnancy beyond 12 weeks is not a sensible rationale for LH supplementation during ovarian stimulation for IVF using GnRH analogues.
Reproductive BioMedicine OnlineWho needs LH in ovarian stimulation?
60 Citations2011Carlo Alviggi, Roberto Clarizia +3 more
Well calibrated LH administration improves the ovarian outcome in patients >35 years, in those showing an initial abnormal ovarian response to r-hFSH monotherapy, and in 'low prognosis' women treated with GnRH antagonists.
Reproductive BioMedicine OnlineWho needs LH in ovarian stimulation?
43 Citations2006Carlo Alviggi, Roberto Clarizia +3 more
Well calibrated LH administration improves the ovarian outcome in patients >35 years, in those showing an initial abnormal ovarian response to r-hFSH monotherapy, and in 'low prognosis' women treated with GnRH antagonists.
EndocrinologyDynamics of gonadotropin-releasing hormone release during a pulse
42 Citations1992Suzanne M. Moenter
Reproductive BioMedicine OnlineRole of LH in ovarian stimulation: considerations
18 Citations2006Georg Griesinger, Klaus Diedrich
Most trials on LH supplementation in general populations in both GnRH agonist and GnRH antagonist protocols have not found a benefit of LH supplementation, although it has been indicated that some subgroups, such as older age patients, or patients with a low ovarian response might benefit from LH.